Global AI in Clinical Trials Market Overview 2023-2035: AI Integration Offers Hope in Streamlining Drug Development

The global AI in clinical trials market is projected to grow at a CAGR of 16% from 2023 to 2035, reaching $1.4 billion in 2023. AI integration aims to improve drug development by automating tasks, optimizing research, and addressing trial design, patient recruitment, and data interpretation challenges. Investment in AI companies focused on healthcare surged to over $20 billion in the first nine months of 2021. Key players include AiCure, Ancora.ai, Deep 6 AI, Intelligencia, and nQ Medical.